|The Lady Davis Institute for Medical Research, thanks to co-funding from the Génome
Québec Centre, has recently acquired SELDI-TOF technology. The platform, located
at the Segal Cancer Centre in Montreal, complements the proteomics services offered
by the McGill University and Génome Québec Innovation Centre. Researchers can
have access to the technology as a not-for profit fee service.
SELDI-TOF is a versatile proteomics research tool that combines retentate chromatography
and time-of-flight mass spectrometry to facilitate the analysis of complex sample mixtures.
It was designed for high-throughput proteomic profiling and biomarker discovery using very
small sample volumes.